All Clinical Trials

< Back to search

Filter

Filter results

Results: 25

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

for

Psoriasis

Location: Birmingham AL, San Antonio TX, Chula Vista CA

Sponsor: InventisBio Co., Ltd

Sex: All

Age: 18 - 70

Code: NCT07489885

Phase2, Recruiting

Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT).

for

Psoriasis Vulgaris

Location: Brooklyn NY

Sponsor: Narrows Institute for Biomedical Research

Sex: All

Age: 18+

Code: NCT03307447

Recruiting

Augmenting Standard-of-care Treatment of Plaque Psoriasis by Neuromodulation

for

Psoriasis Vulgaris

Location: Las Cruces NM

Sponsor: Burrell College of Osteopathic Medicine

Sex: All

Age: 18+

Code: NCT05243303

Recruiting

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

for

Psoriasis

Location: Philadelphia PA, Pompano Beach FL, Fargo ND

Sponsor: SFA Therapeutics

Sex: All

Age: 18+

Code: NCT05642182

Phase1, Recruiting

Modifying PEST for Psoriatic Arthritis Screening

for

Plaque Psoriasis, Psoriatic Arthritis

Location: Ste-Foy, Fredericton, Richmond Hill, Toronto, Montreal,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06382051

Recruiting

Filter results

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT).

Augmenting Standard-of-care Treatment of Plaque Psoriasis by Neuromodulation

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Modifying PEST for Psoriatic Arthritis Screening

Interested in new plaque psoriasis trials?